Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,612 | 47,078 | 10,930 | 36,219 | 25,146 |
| Receivables | 12,497 | 11,858 | 17,509 | 25,846 | 242 |
| Inventories | 10,630 | 2,055 | 1,505 | 1,354 | N/A |
| Other current assets | 0 | 271 | 755 | 0 | 0 |
| TOTAL | $45,911 | $63,100 | $31,618 | $65,036 | $25,501 |
| Non-Current Assets | |||||
| PPE Net | 1,384 | 1,276 | 363 | 441 | N/A |
| Intangibles | 253,404 | 252,050 | 271,153 | 312,659 | N/A |
| Other Non-Current Assets | 3,207 | 3,245 | 3,291 | 6,510 | 23 |
| TOTAL | $257,995 | $256,571 | $274,807 | $319,610 | $23 |
| Total Assets | $303,906 | $319,671 | $306,425 | $384,646 | $25,524 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,750 | 5,625 | 5,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 14,223 | 13,466 | 12,405 | 12,596 | 440 |
| Other current liabilities | 6,216 | 21,812 | 13,920 | 14,160 | N/A |
| TOTAL | $35,642 | $47,139 | $38,268 | $34,602 | $452 |
| Non-Current Liabilities | |||||
| Long Term Debt | 96,205 | 86,582 | 91,707 | 136,706 | N/A |
| Other Non-Current Liabilities | 2,034 | 4,755 | 12,752 | 21,408 | 100 |
| TOTAL | $99,015 | $94,333 | $109,668 | $169,662 | $100 |
| Total Liabilities | $134,657 | $141,472 | $147,936 | $204,264 | $552 |
| Shareholders' Equity | |||||
| Common Shares | 257,411 | 248,687 | 210,360 | 192,743 | 21,103 |
| Retained earnings | -101,575 | -81,468 | -57,389 | -30,632 | 3,336 |
| Other shareholders' equity | 2,020 | -537 | -7,455 | 5,941 | 8 |
| TOTAL | $169,249 | $178,199 | $158,489 | $180,382 | $24,972 |
| Total Liabilities And Equity | $303,906 | $319,671 | $306,425 | $384,646 | $25,524 |